COMMUNIQUÉS West-GlobeNewswire

-
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
02/02/2024 -
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
02/02/2024 -
Nurexone Biologic Initiates European Orphan Drug Designation Process Following U.S. Grant
02/02/2024 -
Mydecine Innovations Group Announces Director Resignation
02/02/2024 -
Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
02/02/2024 -
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
02/02/2024 -
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
02/02/2024 -
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/02/2024 -
The International Myeloma Foundation (IMF) Welcomes Dr. S. Vincent Rajkumar as Chairperson of the Board
02/02/2024 -
NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
02/02/2024 -
TeamHealth launches new value-based care initiative, TeamACO
02/02/2024 -
Cooperative of American Physicians’ Mutual Protection Trust Earns 17th Consecutive A.M. Best A+ (Superior) Rating
02/02/2024 -
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
02/02/2024 -
Women’s Health Advocates Call on Province of New Brunswick and Premier Higgs to act urgently following the closure announcement of Clinic 554
02/02/2024 -
Un défenseur de la santé des femmes demande à la province du Nouveau-Brunswick et au premier ministre Higgs d'agir de façon urgente suite à l'annonce de la fermeture de la clinique 554
02/02/2024 -
BioSenic raises €500,000 in private placement of new shares with established new investors
02/02/2024 -
BioSenic lève 500 000 euros dans le cadre d'un placement privé d'actions nouvelles auprès de nouveaux investisseurs établis
02/02/2024 -
Cingulate Announces Pricing of $7.5 Million Public Offering
02/02/2024 -
Evaxion Biotech fixe le prix de son offre publique à 15 millions de dollars
02/02/2024
Pages